TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market – By Type
1.3.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product
1.3.3 Global Prostate Cancer Nuclear Medicine Diagnostics Market – By End User
1.3.4 Global Prostate Cancer Nuclear Medicine Diagnostics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Prostate Cancer
5.1.2 Surging Demand for Early and Precise Diagnosis of Prostate Cancer
5.2 Market Restraints
5.2.1 High Cost Related to the Prostate Cancer Diagnostics and Treatment
5.3 Market Opportunities
5.3.1 Growing Use of Radiopharmaceuticals in Prostate Cancer
5.4 Future Trends
5.4.1 Increasing Research Activities for Development of Innovative Imaging Agents
5.5 Impact Analysis
6. Prostate Cancer Nuclear Medicine Diagnostics Market– Global Analysis
6.1 Global Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis
6.2 Global Prostate Cancer Nuclear Medicine Diagnostics Market, By Geography - Forecast and Analysis
6.3 Company Analysis
6.3.1 Market Positioning of Key Players
6.3.2 Comparative Company Analysis
6.3.3 Growth Strategy Analysis
6.3.4 Performance of Key Players
6.3.4.1 Novartis AG
6.3.4.2 Jubilant Radiopharma
6.3.4.3 Curium
7. Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)
7.3 SPECT
7.3.1 Overview
7.3.2 SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 PET
7.4.1 Overview
7.4.2 PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product
8.1 Overview
8.2 Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)
8.3 F-18
8.3.1 Overview
8.3.2 F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 C-11
8.4.1 Overview
8.4.2 C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 GA 68 PSMA
8.5.1 Overview
8.5.2 GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. Global Prostate Cancer Nuclear Medicine Diagnostics Market – Geographic Analysis
10.1 North America: Prostate Cancer Nuclear Medicine Diagnostics Market
10.1.1 Overview
10.1.2 North America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.3 North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.4 North America: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.1.5 North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.1.6 North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.3 US: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.1.4 US: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.1.6.1.5 US: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.1.6.2 Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.3 Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.2.4 Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.1.6.2.5 Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.1.6.3 Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.3 Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.3.4 Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.1.6.3.5 Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.2 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market
10.2.1 Overview
10.2.2 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.4 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
10.2.6.1 Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.4 Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.4 France: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.4 UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.4 Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.4 Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market
10.3.1 Overview
10.3.2 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6 Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
10.3.6.1 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.1.4 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.1.5 China: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.3.4 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.3.5 India: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.4.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.4.5 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.5.4 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.5.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.3.6.6 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.4 Middle East & Africa Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.3 Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.4 Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.4.5 Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ Million)
10.4.6 Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2021 & 2028 (%)
10.4.6.1 UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.1 Overview
10.4.6.1.2 UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.1.3 UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.1.4 UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.4.6.1.5 UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.4.6.2 Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.1 Overview
10.4.6.2.2 Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.2.3 Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.2.4 Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.4.6.2.5 Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.4.6.3 South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.3.3 South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.3.4 South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.4.6.3.5 South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.4.6.4 Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.4.6.4.3 Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)
10.4.6.4.4 Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)
10.4.6.4.5 Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)
10.5 South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)
10.5.4 South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2019–2028 (USD Million)
10.5.5 South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (USD Million)
10.5.6 South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
10.5.6.1 Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.3 Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)
10.5.6.1.4 Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2019–2028 (USD Million)
10.5.6.1.5 Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (USD Million)
10.5.6.2 Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.3 Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)
10.5.6.2.4 Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2019–2028 (USD Million)
10.5.6.2.5 Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market , by PET Product, 2019–2028 (USD Million)
10.5.6.3.5 Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market , by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Prostate Cancer Nuclear Medicine Diagnostics Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Blue Earth Diagnostics Limited
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 ImaginAb
13.2.1 1.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Curium
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Jubilant Radiopharma
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 NCM-USA LLC
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 ABX advanced biochemical compounds GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Telix Pharmaceuticals Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novartis AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Theragnostics
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Lantheus Medical Imaging, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. North America: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. US: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. US: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. US: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. France: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. France: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 21. France: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 24. UK: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 28. Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 37. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 39. China Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 40. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 43. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type– Revenue and Forecast to 2028 (US$ Million)
Table 44. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 45. India Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 46. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 48. Australia Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 49. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 51. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 52. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 55. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 56. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 57. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 59. UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 60. UAE: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 61. Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 62. Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 63. Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 64. South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 65. South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 66. South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 67. Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 68. Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 69. Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)
Table 70. South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product – Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 82. Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 83. Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 84. Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market
LIST OF FIGURES.
Figure 1. Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation
Figure 2. Prostate Cancer Nuclear Medicine Diagnostics Market, By Region
Figure 3. Global Prostate Cancer Nuclear Medicine Diagnostics Market Overview
Figure 4. PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Prostate Cancer Nuclear Medicine Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Prostate Cancer Nuclear Medicine Diagnostics Market- Leading Country Markets (US$ Million)
Figure 8. Global Prostate Cancer Nuclear Medicine Diagnostics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 16. Global Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2020 - 2028
Figure 17. Global Prostate Cancer Nuclear Medicine Diagnostics Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players In Global Prostate Cancer Nuclear Medicine Diagnostics Market
Figure 19. Global Prostate Cancer Nuclear Medicine Diagnostics Market – Comparative Company Analysis
Figure 20. Global Prostate Cancer Nuclear Medicine Diagnostics Market – Growth Strategy Analysis
Figure 21. Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)
Figure 22. SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)
Figure 25. F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 27. GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)
Figure 29. Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ ‘Million)
Figure 33. North America: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 34. North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 35. US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 36. Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 37. Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 38. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 39. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 41. Germany: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. UK: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Italy: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Spain: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of Europe: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 48. Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 49. Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 50. China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 57. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 58. Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 59. UAE: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 60. Saudi Arabia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 61. South Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 62. Rest of Middle East and Africa: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 63. South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (USD Million)
Figure 64. South and Central America Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (USD Million)
Figure 65. South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 66. Brazil: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Argentina: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of South and Central America: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 70. Impact of COVID-19 Pandemic in European Country Markets
Figure 71. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 72. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 73. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 74. Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028